Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

Clinical trial NCT05527418 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05527418
Sponsor: Eva Bonfill
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recent HIV-1 Infection

Start date: 2024-01-26
Primary completion: 2026-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.